Literature DB >> 33484635

Development of a potent and selective chemical probe for the pleiotropic kinase CK2.

Carrow I Wells1, David H Drewry1, Julie E Pickett1, Amelie Tjaden2, Andreas Krämer2, Susanne Müller2, Laszlo Gyenis3, Daniel Menyhart3, David W Litchfield4, Stefan Knapp2, Alison D Axtman5.   

Abstract

Building on the pyrazolopyrimidine CK2 (casein kinase 2) inhibitor scaffold, we designed a small targeted library. Through comprehensive evaluation of inhibitor selectivity, we identified inhibitor 24 (SGC-CK2-1) as a highly potent and cell-active CK2 chemical probe with exclusive selectivity for both human CK2 isoforms. Remarkably, despite years of research pointing to CK2 as a key driver in cancer, our chemical probe did not elicit a broad antiproliferative phenotype in >90% of >140 cell lines when tested in dose-response. While many publications have reported CK2 functions, CK2 biology is complex and an available high-quality chemical tool such as SGC-CK2-1 will be indispensable in deciphering the relationships between CK2 function and phenotypes.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CK2; IDG; cancer; casein kinase 2; chemical probe; crystal structure; kinase; nanoBRET; proliferation; small molecule

Mesh:

Substances:

Year:  2021        PMID: 33484635      PMCID: PMC8864761          DOI: 10.1016/j.chembiol.2020.12.013

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  65 in total

Review 1.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

2.  Protein kinase CK2 phosphorylates and upregulates Akt/PKB.

Authors:  G Di Maira; M Salvi; G Arrigoni; O Marin; S Sarno; F Brustolon; L A Pinna; M Ruzzene
Journal:  Cell Death Differ       Date:  2005-06       Impact factor: 15.828

3.  Leveraging the Pre-DFG Residue Thr-406 To Obtain High Kinase Selectivity in an Aminopyrazole-Type PAK1 Inhibitor Series.

Authors:  Joachim Rudolph; Ignacio Aliagas; James J Crawford; Simon Mathieu; Wendy Lee; Qi Chao; Ping Dong; Lionel Rouge; Weiru Wang; Christopher Heise; Lesley J Murray; Hank La; Yanzhou Liu; Gerard Manning; François Diederich; Klaus P Hoeflich
Journal:  ACS Med Chem Lett       Date:  2015-05-20       Impact factor: 4.345

4.  Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195.

Authors:  Yunsong Tong; Kent D Stewart; Alan S Florjancic; John E Harlan; Philip J Merta; Magdalena Przytulinska; Nirupama Soni; Kerren K Swinger; Haizhong Zhu; Eric F Johnson; Alexander R Shoemaker; Thomas D Penning
Journal:  ACS Med Chem Lett       Date:  2013-01-15       Impact factor: 4.345

5.  Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization.

Authors:  James E Dowling; Claudio Chuaqui; Timothy W Pontz; Paul D Lyne; Nicholas A Larsen; Michael H Block; Huawei Chen; Nancy Su; Allan Wu; Daniel Russell; Hannah Pollard; John W Lee; Bo Peng; Kumar Thakur; Qing Ye; Tao Zhang; Patrick Brassil; Vicki Racicot; Larry Bao; Christopher R Denz; Emma Cooke
Journal:  ACS Med Chem Lett       Date:  2012-01-24       Impact factor: 4.345

6.  Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CK I and CK II from Saccharomyces cerevisiae and other sources.

Authors:  R Szyszka; N Grankowski; K Felczak; D Shugar
Journal:  Biochem Biophys Res Commun       Date:  1995-03-08       Impact factor: 3.575

Review 7.  Joining the cell survival squad: an emerging role for protein kinase CK2.

Authors:  Khalil Ahmed; Delphine A Gerber; Claude Cochet
Journal:  Trends Cell Biol       Date:  2002-05       Impact factor: 20.808

8.  Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.

Authors:  Laszlo Gyenis; James S Duncan; Jacob P Turowec; Maria Bretner; David W Litchfield
Journal:  J Proteome Res       Date:  2011-10-13       Impact factor: 4.466

9.  SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2K.

Authors:  Carrow Wells; Rafael M Couñago; Juanita C Limas; Tuanny L Almeida; Jeanette Gowen Cook; David H Drewry; Jonathan M Elkins; Opher Gileadi; Nirav R Kapadia; Alvaro Lorente-Macias; Julie E Pickett; Alexander Riemen; Roberta R Ruela-de-Sousa; Timothy M Willson; Cunyu Zhang; William J Zuercher; Reena Zutshi; Alison D Axtman
Journal:  ACS Med Chem Lett       Date:  2019-10-23       Impact factor: 4.632

Review 10.  The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review).

Authors:  Fatima Ardito; Michele Giuliani; Donatella Perrone; Giuseppe Troiano; Lorenzo Lo Muzio
Journal:  Int J Mol Med       Date:  2017-06-22       Impact factor: 4.101

View more
  15 in total

Review 1.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

2.  Identification and Utilization of a Chemical Probe to Interrogate the Roles of PIKfyve in the Lifecycle of β-Coronaviruses.

Authors:  David H Drewry; Frances M Potjewyd; Armin Bayati; Jeffery L Smith; Rebekah J Dickmander; Stefanie Howell; Sharon Taft-Benz; Sophia M Min; Mohammad Anwar Hossain; Mark Heise; Peter S McPherson; Nathaniel J Moorman; Alison D Axtman
Journal:  J Med Chem       Date:  2022-09-16       Impact factor: 8.039

3.  Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC Quantitative Phosphoproteomics.

Authors:  Laszlo Gyenis; Daniel Menyhart; Edward S Cruise; Kristina Jurcic; Scott E Roffey; Darren B Chai; Flaviu Trifoi; Sam R Fess; Paul J Desormeaux; Teresa Núñez de Villavicencio Díaz; Adam J Rabalski; Stephanie A Zukowski; Jacob P Turowec; Paula Pittock; Gilles Lajoie; David W Litchfield
Journal:  Front Mol Biosci       Date:  2022-06-09

4.  Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma.

Authors:  Anne S Boewe; Silke Wemmert; Philipp Kulas; Bernhard Schick; Claudia Götz; Selina Wrublewsky; Mathias Montenarh; Michael D Menger; Matthias W Laschke; Emmanuel Ampofo
Journal:  Biomedicines       Date:  2022-04-21

5.  Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2.

Authors:  Xuan Yang; Rebekah J Dickmander; Armin Bayati; Sharon A Taft-Benz; Jeffery L Smith; Carrow I Wells; Emily A Madden; Jason W Brown; Erik M Lenarcic; Boyd L Yount; Edcon Chang; Alison D Axtman; Ralph S Baric; Mark T Heise; Peter S McPherson; Nathaniel J Moorman; Timothy M Willson
Journal:  bioRxiv       Date:  2022-01-26

6.  4,5,7-Trisubstituted indeno[1,2-b]indole inhibits CK2 activity in tumor cells equivalent to CX-4945 and shows strong anti-migratory effects.

Authors:  Robin Birus; Ehab El-Awaad; Laurens Ballentin; Faten Alchab; Dagmar Aichele; Laurent Ettouati; Claudia Götz; Marc Le Borgne; Joachim Jose
Journal:  FEBS Open Bio       Date:  2021-12-18       Impact factor: 2.693

Review 7.  CSNK2 in cancer: pathophysiology and translational applications.

Authors:  Scott W Strum; Laszlo Gyenis; David W Litchfield
Journal:  Br J Cancer       Date:  2021-11-12       Impact factor: 9.075

8.  CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(-) HNSCC Cell Lines.

Authors:  Janeen H Trembley; Bin Li; Betsy T Kren; Amy A Gravely; Emiro Caicedo-Granados; Mark A Klein; Khalil Ahmed
Journal:  Biomedicines       Date:  2021-05-18

9.  SGC-CK2-1 Is an Efficient Inducer of Insulin Production and Secretion in Pancreatic β-Cells.

Authors:  Mandy Pack; Claudia Götz; Selina Wrublewsky; Mathias Montenarh
Journal:  Pharmaceutics       Date:  2021-12-22       Impact factor: 6.321

10.  Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving Neurodegeneration.

Authors:  David H Drewry; Joel K Annor-Gyamfi; Carrow I Wells; Julie E Pickett; Verena Dederer; Franziska Preuss; Sebastian Mathea; Alison D Axtman
Journal:  J Med Chem       Date:  2021-08-01       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.